Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma
A Ingels, R Campi, U Capitanio, D Amparore… - Nature Reviews …, 2022 - nature.com
Standard-of-care management of renal cell carcinoma (RCC) indisputably relies on surgery
for low-risk localized tumours and systemic treatment for poor-prognosis metastatic disease …
for low-risk localized tumours and systemic treatment for poor-prognosis metastatic disease …
First-line treatments for metastatic clear cell renal cell carcinoma: an ever-enlarging landscape
Abstract Treatment paradigm for metastatic clear cell renal cell carcinoma (mccRCC) has
changed dramatically over the recent decades. From cytokines, interleukin-2 and interferon …
changed dramatically over the recent decades. From cytokines, interleukin-2 and interferon …
The role of cytoreductive nephrectomy in metastatic renal cell carcinoma: a real-world multi-institutional analysis
P Ghatalia, EA Handorf, DM Geynisman… - The Journal of …, 2022 - auajournals.org
Purpose: The role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma
(mRCC) was challenged by the results of the CARMENA trial. Here we evaluate the role of …
(mRCC) was challenged by the results of the CARMENA trial. Here we evaluate the role of …
Pathological outcomes of patients with advanced renal cell carcinoma who receive nephrectomy following immunotherapy
Background Even though cytoreductive nephrectomy (CN) was once the standard of care for
patients with advanced renal cell carcinoma (RCC), its role in treatment has not been well …
patients with advanced renal cell carcinoma (RCC), its role in treatment has not been well …
[HTML][HTML] Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma
C Van Praet, C Slots, N Vasdev, S Rottey… - Turkish Journal of …, 2021 - ncbi.nlm.nih.gov
Historically, immediate cytoreductive nephrectomy (CN) was considered the standard of
care in patients with metastatic renal cell carcinoma (mRCC) who were fit enough to …
care in patients with metastatic renal cell carcinoma (mRCC) who were fit enough to …
Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immune-oncology: a real-world study on behalf of Meet-URO Group …
M Stellato, D Santini, E Verzoni, U De Giorgi… - Frontiers in …, 2021 - frontiersin.org
Background Immune-Oncology (IO) improves Overall Survival (OS) in metastatic Renal Cell
Carcinoma (mRCC). The prognostic impact of previous Cytoreductive Nephrectomy (CN) …
Carcinoma (mRCC). The prognostic impact of previous Cytoreductive Nephrectomy (CN) …
Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma
T Hara, J Furukawa, Y Shiraishi… - … Journal of Urology, 2023 - Wiley Online Library
Objectives The efficacy of cytoreductive nephrectomy (CN) for metastatic renal cell
carcinoma (mRCC) treated with immune checkpoint inhibitors (ICIs) has been suggested in …
carcinoma (mRCC) treated with immune checkpoint inhibitors (ICIs) has been suggested in …
[HTML][HTML] Stereotactic body radiation therapy to the kidney for metastatic renal cell carcinoma: A narrative review of an emerging concept
This narrative review provides a historical overview of cytoreductive nephrectomy for
metastatic renal cell carcinoma (mRCC) and examines the safety and therapeutic potential …
metastatic renal cell carcinoma (mRCC) and examines the safety and therapeutic potential …
Cytoreductive nephrectomy following immunotherapy-base treatment in metastatic renal cell carcinoma: a case series and review of current literature
SJ Dawsey, SC Campbell, MC Ornstein - Current Oncology, 2021 - mdpi.com
The role and timing of cytoreductive nephrectomy in patients with metastatic renal cell
carcinoma receiving immunotherapy-based regimens is unclear. However, the ability to …
carcinoma receiving immunotherapy-based regimens is unclear. However, the ability to …
Three years after CARMENA: what have we learned?
E Roussel, B Beuselinck, M Albersen - European Urology, 2021 - europepmc.org
Cytoreductive nephrectomy makes way for more effective systemic treatments in the current
mRCC treatment paradigm, as disease volume and the number of IMDC risk factors …
mRCC treatment paradigm, as disease volume and the number of IMDC risk factors …